ArticleFrontiers in cardiovascular medicine2025
The outcome of possible events following the hospital discharge of patients with HFmrEF after MI as compared with those with HFmrEF without MI: a propensity score matching analysis.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Clinical studies on heart failure (HF) with mildly reduced left ventricular ejection fraction (HFmrEF) are gradually increasing. However, relatively few studies have examined patients with HFmrEF after myocardial infarction (MI), and the prognosis of such patients remains unclear. Therefore, we conducted a retrospective evaluation of HFmrEF patients with/without MI using a propensity score matching analysis (PSMA). Methods: A total of 1,691 patients with HFmrEF were included in this study. Of these patients, 873 had a diagnosis of MI, and 818 did not. After propensity score matching, we used Kaplan-Meier analysis and Cox regression to compare all-cause mortality, cardiovascular death, or HF readmission (CV events). Results: After the first PSMA, the MI group had a lower risk of all-cause mortality [hazard ratio (HR) 0.6; 95% confidence interval (95% CI) 0.5-0.8] compared with the non-MI group; however, there was no significant difference in the incidence of CV events (HR 0.9; 95% CI 0.7-1.2). After the second PSMA, which additionally matched for PCI performance in the MI group, there were no differences in the risk of all-cause mortality (HR 1.0; 95% CI 0.7-1.5) or CV events (HR 1.1; 95% CI 0.8-1.5) between the MI and non-MI groups. Conclusions: There was no difference in all-cause mortality and CV events between patients with HFmrEF with and without MI. However, among patients with HFmrEF and MI, those who underwent PCI had a much lower risk of all-cause mortality compared with patients with HFmrEF without MI and those with HFmrEF after MI who did not undergo PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.